炎症
牙周炎
氧化应激
免疫系统
癌症研究
多胺
化学
牙槽
活性氧
医学
免疫学
发病机制
组织修复
细胞生物学
T细胞
氧化磷酸化
细胞
骨愈合
药理学
慢性牙周炎
调解人
骨重建
巨噬细胞极化
代谢活性
作者
Cheng Zhu,Tiancheng Li,Yu Jin,Yixin Li,Qicheng Liu,Runzhe Fang,Luyao Qu,Xinyue Tang,Ruomei Li,Xiaoyue Zhao,Jin Hao,Bing Fang,Lunguo Xia
摘要
Periodontitis is a chronic inflammatory disease characterized by persistent inflammation and limited repair at sites of alveolar bone loss. Although excessive reactive oxygen species (ROS) are recognized drivers of periodontal tissue damage, oxidative stress alone does not fully explain the persistence of inflammation and the failure of regeneration. The immune and metabolic processes that cooperate with oxidative stress in sustaining this disease‐supporting microenvironment remain incompletely defined. In this study, a pronounced T H 17‐skewed CD4 + T cell response is identified in experimental periodontitis, and enrichment of polyamine pathway activation is observed during T H 17 differentiation, suggesting a candidate immunometabolic axis for intervention. Guided by this observation, difluoromethylornithine‐loaded UiO‐66(Ce)‐Mn (DFMO@Ui‐Mn) is developed as a nanozyme platform that integrates the cascade ROS‐scavenging activity of UiO‐66(Ce)‐Mn with DFMO delivery for inhibition of polyamine metabolism. DFMO@Ui‐Mn reduces T H 17 polarization in vitro, alters polyamine‐related metabolic profiles, attenuates inflammatory responses in vivo, lowers the T H 17/Treg ratio, improves osteogenic readouts in a conditioned‐medium model, and promotes alveolar bone repair in ligature‐induced periodontitis. These findings support a therapeutic strategy that combines redox control with immunometabolic intervention to improve the periodontal microenvironment under inflammatory conditions.
科研通智能强力驱动
Strongly Powered by AbleSci AI